7-18yr Schedule For Immunizations, CDC 2008

Download as pdf or txt
Download as pdf or txt
You are on page 1of 1

Recommended Immunization Schedule for Persons Aged 7–18 Years—UNITED STATES • 2008

For those who fall behind or start late, see the green bars and the catch-up schedule

Vaccine  Age  7–10 years 11–12 years 13–18 years

Diphtheria, Tetanus, Pertussis1 see footnote 1 Tdap Tdap


Range of
Human Papillomavirus2 see footnote 2 HPV (3 doses) HPV Series recommended
ages
Meningococcal3 MCV4 MCV4 MCV4

Pneumococcal4 PPV
Catch-up
Influenza5 Influenza (Yearly) immunization

Hepatitis A6 HepA Series

Hepatitis B7 HepB Series Certain


high-risk
Inactivated Poliovirus8 IPV Series groups

Measles, Mumps, Rubella9 MMR Series

Varicella10 Varicella Series


This schedule indicates the recommended ages for routine administration of currently contraindicated and if approved by the Food and Drug Administration for that dose
licensed childhood vaccines, as of December 1, 2007, for children aged 7–18 years. of the series. Providers should consult the respective Advisory Committee on
Additional information is available at www.cdc.gov/vaccines/recs/schedules. Any dose Immunization Practices statement for detailed recommendations, including for
not administered at the recommended age should be administered at any subsequent high-risk conditions: http://www.cdc.gov/vaccines/pubs/ACIP-list.htm. Clinically
visit, when indicated and feasible. Additional vaccines may be licensed and recommended significant adverse events that follow immunization should be reported to
during the year. Licensed combination vaccines may be used whenever any components the Vaccine Adverse Event Reporting System (VAERS). Guidance about how to obtain and
of the combination are indicated and other components of the vaccine are not complete a VAERS form is available at www.vaers.hhs.gov or by telephone, 800-822-7967.

1. Tetanus and diphtheria toxoids and acellular pertussis • Administer 2 doses (separated by 4 weeks or longer) to children younger
vaccine (Tdap). (Minimum age: 10 years for BOOSTRIX® and than 9 years who are receiving influenza vaccine for the first time or who
were vaccinated for the first time last season but only received one dose.
11 years for ADACEL™)    • F
 or healthy nonpregnant persons (those who do not have underlying
• Administer at age 11–12 years for those who have completed the medical conditions that predispose them to influenza complications)
recommended childhood DTP/DTaP vaccination series and have ages 2–49 years, either LAIV or TIV may be used.
not received a tetanus and diphtheria toxoids (Td) booster dose.
• 13–18-year-olds who missed the 11–12 year Tdap or received Td 6. Hepatitis A vaccine (HepA).
only are encouraged to receive one dose of Tdap 5 years after the •A
 dminister the 2 doses in the series at least 6 months apart.
last Td/DTaP dose. •H
 epA is recommended for certain other groups of children, including
in areas where vaccination programs target older children.
2. Human papillomavirus vaccine (HPV). (Minimum age: 9 years)
• Administer the first dose of the HPV vaccine series to females at age 7. Hepatitis B vaccine (HepB).
11–12 years. • Administer the 3-dose series to those who were not previously
• Administer the second dose 2 months after the first dose and the vaccinated.
third dose 6 months after the first dose. •A  2-dose series of Recombivax HB® is licensed for children aged
• Administer the HPV vaccine series to females at age 13–18 years if 11–15 years.
not previously vaccinated. 8. Inactivated poliovirus vaccine (IPV).
3. Meningococcal vaccine. • For children who received an all-IPV or all-oral poliovirus (OPV) series,
• Administer MCV4 at age 11–12 years and at age 13–18 years if not a fourth dose is not necessary if the third dose was administered at
previously vaccinated. MPSV4 is an acceptable alternative. age 4 years or older.
• Administer MCV4 to previously unvaccinated college freshmen • If both OPV and IPV were administered as part of a series, a total of 4
living in dormitories. doses should be administered, regardless of the child’s current age.
• MCV4 is recommended for children aged 2–10 years with terminal 9. Measles, mumps, and rubella vaccine (MMR).
complement deficiencies or anatomic or functional asplenia and • If not previously vaccinated, administer 2 doses of MMR during any
certain other high-risk groups. visit, with 4 or more weeks between the doses.
•P ersons who received MPSV4 3 or more years previously and remain at
increased risk for meningococcal disease should be vaccinated with MCV4.
10. Varicella vaccine.
•A
 dminister 2 doses of varicella vaccine to persons younger than
4. P neumococcal polysaccharide vaccine (PPV). 13 years of age at least 3 months apart. Do not repeat the second
• Administer PPV to certain high-risk groups. dose if administered 28 or more days following the first dose.
•A
 dminister 2 doses of varicella vaccine to persons aged 13 years or
5. Influenza vaccine. older at least 4 weeks apart.
• Administer annually to all close contacts of children aged 0–59 months.
• Administer annually to persons with certain risk factors, health-care
workers, and other persons (including household members) in close
contact with persons in groups at higher risk. 

The Recommended Immunization Schedules for Persons Aged 0–18 Years are approved by the Advisory Committee on Immunization Practices (www.cdc.gov/vaccines/recs/acip),
the American Academy of Pediatrics (http://www.aap.org), and the American Academy of Family Physicians (http://www.aafp.org).
CS103164

Department of Health and Human Services • Centers for Disease Control and Prevention

You might also like